Drug intelligence / Profile preview

OSW-1

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Intraperitoneal (experimental, Preclinical Studies)
01

Overview

**OSW-1** is a natural steroidal saponin primarily isolated from the bulbs of *Ornithogalum saundersiae*. It exhibits extremely potent and selective anticancer activity, in vitro and in vivo, across diverse cancer types such as glioma, colorectal, breast, prostate, ovarian, leukemia, and hepatocellular carcinoma. OSW-1 triggers programmed cell death through both apoptosis and necroptosis, exhibiting significantly higher cytotoxicity for cancer cells compared to nonmalignant cells. Its mechanisms of action include inhibition of *oxysterol-binding protein* (OSBP) and OSBP-related protein 4 (ORP4), disruption of intracellular lipid trafficking, induction of endoplasmic reticulum stress, mitochondrial membrane damage, modulation of the p53/PUMA pathway, cytosolic calcium influx, and inhibition of the PI3K/AKT pathway. The induced forms of cell death are highly immunogenic, potentiating antitumor immunity and synergizing with immunotherapy. OSW-1 also demonstrates significant inhibition of tumor growth, colony formation, and migration, with low systemic toxicity observed in animal models[1][2][3][4][5][11].

Other names
3beta,16beta,17alpha-trihydroxycholest-5-en-22-one 16-O-(2-O-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1→3)-(2-O-acetyl-alpha-L-arabinopyranoside)Orsaponin
02

Targets

OSBP2 (Oxysterol-binding protein 1)ENO (Alpha-enolase)

Beyond the preview

Go deeper on OSW-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OSW-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call